DCT

2:15-cv-01471

Warner Chilcott US LLC v. Teva Pharma USA Inc

General

Filed

08/28/15

Cause of ActionInfringement

SectorChemical

Status

Closed (11/13/17)

Patent Owner

NPE (L)

PACER2:15-cv-01471

Appeals18-1241

CourtE.D. Texas

Judge	Period	PO Win Rate
James R. Gilstrap	--	33%

Plaintiff

Party

Name	Ratings
Warner Chilcott US LLC NPE	L5E
Warner Chilcott Co LLC NPE	L5E
Allergan Sales LLC NPE	L5E
Allergan USA Inc	L5E
Allergan Pharmaceuticals Intl Ltd	L5E
Allergan Inc	L5E
Qualicaps Co Ltd	L3D

Attorney

Name	Ratings
Gillam & Smith LLPLocal	L5A
Melissa R. Smith	L5A
Potter MintonLocal	L5A
Michael E. Jones	L5A
John F. Bufe	L4A
Ward & Smith Law FirmLocal	L5E
Jack W. Hill	L5A
Claire A. Henry	L4E
Andrea L. Fair	L2B
Covington & Burling LLP	L4B
George F. Pappas	L5A
Jeffrey B. Elikan	L5A
Michael N. Kennedy	L4C
David S. Denuyl	L4C
Daniel W. Cho	L4C
Jeremy D. Cobb	L3C
Brianne B. Sullivan	L3C
Ahmed Mousa	L2C

Defendant

Party

Name	Ratings
Teva Pharmaceuticals USA Inc	L5E
Mylan Laboratories Ltd	L5A
Mylan Inc	L5A
Mylan Pharmaceuticals Inc	L5E
Teva Pharmaceutical Industries Ltd	L5E

Attorney

Name	Ratings
Kilpatrick Townsend & Stockton LLP	L5A
D. Clay Holloway	L5B
Mitchell G. Stockwell	L5C
Amanda N. Brouillette	L4B
Jonathan D. Olinger	L3C
Capshaw Derieux LLPLocal	L5D
S. Calvin Capshaw	L4A
Elizabeth L. Derieux	L4C
Nix Patterson Roach LLPLocal	L2C
Louis B. Paddock	L1B
Kellogg Huber Hansen Todd Evans Figel PLLC	L2D
John C. Rozendaal	L5C
Michael E. Joffre	L5C
Miles J. Sweet	L1-- --
Sterne Kessler Goldstein & Fox	L2E
Daniel J. Ritterbeck	L4D
Chandrika Vira	L3D
William H. Milliken	L2A